Amiodarone is a commonly used antiarrhythmic used to treat atrial fibrillation and ventricular
tachycardias. While this agent can present with pulmonary, thyroid, and hepatic side effects …

Amiodarone is a commonly prescribed and one of the most effective anti-arrhythmic drugs
available. However, its use is limited by serious toxic adverse effects including optic …

Although amiodarone is the most commonly prescribed anti-arrhythmic drug, its use is
limited by serious toxicities, including optic neuropathy. Current reports of amiodarone …

Optic neuropathy with vision loss is an uncommon but serious event currently considered a
probable amiodarone-associated adverse drug reaction. We report a case of a 72-year-old …

Purpose: To describe the clinical spectrum of amiodarone–induced optic neuropathy, since
early recognition of this disorder is important as permanent visual loss can occur. Methods …

Amiodarone is an anti-arhythmic drug that is used commonly to treat ventricular and supra
ventricular arrhythmia [1]. Its use has increased over the past years due to its efficacy at …

Amiodarone, an antiarrhythmic agent, has been associated with visual loss secondary to
optic neuropathy. The reported mean duration of amiodarone use before visual loss is about …

Purpose:: To report 294 cases of amiodarone–associated optic neuropathy (AON),
representing the largest number of cases reported with this toxicity. Methods:: Reports of …

Amiodarone is one of the most frequently prescribed antiarrhythmic medications. Used in 25
tachycardia and fibrillation management, its efficacy is tempered by clinically-significant drug …

Amiodarone-associated optic neuropathy (AAON) is a controversial diagnosis with possible
impact on vital cardiac therapy decisions. This retrospective case series aims for application …